Cenobamate is an effective treatment for drug resistance focal epilepsy: a critical review

Cenobamate, recently approved anticonvulsant by the Food and Drug Administration (FDA), stands as a potential remedy for drug-resistant epilepsy (DRE). It shows promise in enhancing seizure management efficacy. An in-depth analysis of various literature sources, encompassing clinical trials, preclin...

Full description

Bibliographic Details
Main Authors: Jayasheela S Hiremath, Sanatkumar Bharamu Nyamagoud, Prasannakumar C Bullapur
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:MGM Journal of Medical Sciences
Subjects:
Online Access:http://www.mgmjms.com/article.asp?issn=2347-7946;year=2023;volume=10;issue=4;spage=783;epage=788;aulast=Hiremath